GLP-1 agonists activate specific brain regions controlling hunger within hours, though measurable weight change may not appear on the scale yet
At our La Quinta studio, every program we build for GLP-1 users starts from the same premise: the medication creates the calorie deficit, while resistance training helps preserve the muscle and metabolism underneath the weight loss
Why its awesome: Enhances liver health and contributes to cardiovascular well-being
Retatrutide, identified by its developmental code LY-3437943, is an investigational medication created by Eli Lilly for treating obesity, overweight conditions, and associated metabolic disorders including type 2 diabetes
The litigation continued to broaden in September 2025, with new lawsuits alleging additional gastrointestinal injuries such as ileus , and Eli Lilly filed a motion seeking to centralize federal vision-loss (NAION) claims within MDL 3094 or create a separate MDL under the same judge